Risk Stratification and Prognostic Value of Right Ventricular Dysfunction Screening Using Transthoracic Echocardiography in Acute Pulmonary Embolism

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07647497

Acronym

RVD-PE

Enrollment

112

Registered

2026-06-15

Start date

2026-06-01

Completion date

2026-11-30

Last updated

2026-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Embolism

Keywords

Right Ventricular Dysfunction, Echocardiography, Pulmonary Embolism, Risk Stratification

Brief summary

This observational study evaluates right ventricular dysfunction in patients with acute pulmonary embolism using transthoracic echocardiography and assesses its prognostic significance and risk stratification value.

Detailed description

Interventions

OTHERTransthoracic Echocardiography

Transthoracic echocardiography performed for assessment of right ventricular dysfunction in patients with acute pulmonary embolism.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients aged 18 years and older. * Patients with a confirmed diagnosis of acute pulmonary embolism. * Patients who underwent transthoracic echocardiographic assessment for right ventricular dysfunction.

Exclusion criteria

* Patients younger than 18 years. * Patients with incomplete clinical data. * Patients who did not undergo transthoracic echocardiography.

Design outcomes

Primary

Measure	Time frame	Description
Right ventricular dysfunction as a prognostic marker in acute pulmonary embolism	From hospital admission until hospital discharge, with an average duration of 7 days.	To assess the prognostic value of right ventricular dysfunction detected by transthoracic echocardiography for risk stratification in patients with acute pulmonary embolism

Secondary

Measure	Time frame	Description
In-hospital adverse clinical outcomes	From hospital admission until hospital discharge, with an average duration of 7 days.	To evaluate the occurrence of in-hospital adverse clinical outcomes, including respiratory failure, hemodynamic instability, cardiac arrhythmias, intensive care unit admission, and mortality, and their association with right ventricular dysfunction in patients with acute pulmonary embolism

Countries

Egypt

Contacts

CONTACTSafiya Khalaf Abdallah, Assistant lecturer

olaamer2026@gmail.com0201090720819

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 16, 2026